'Copies' of Ozempic are sold for $14: India launches generics of semaglutide after patent expiration
India has introduced generic versions of semaglutide, the active ingredient in Ozempic, at a lower price following the expiration of its patent.
India drugmakers to sell Ozempic copy for $14 a month as Novo patent expires
Indian drug manufacturers are set to launch generic versions of Ozempic for just $14 a month following the expiration of Novo Nordisk's patent.
Ozempic in the SUS and without a patent: how weight-loss pens have already changed the world — and what’s to come
Rio de Janeiro has become the first Brazilian city to offer the medication Ozempic through the Unified Health System (SUS) as part of its initiative in the fight against obesity.
Anvisa analyzes eight medications with semaglutide; see what changes with the patent expiration
Brazil's health regulatory agency Anvisa is currently reviewing eight semaglutide-based drug applications following the recent patent expiration of the popular medications Ozempic and Wegovy.
Weight Loss Will Reduce by ₹3000! Weight Loss Injections Becoming 70% Cheaper
The patent expiration of the weight loss drug Semaglutide on March 20 will lead to a significant price drop of up to 70% for consumers in India.
The patent for Ozempic expired, revealing an interesting fact about the price of its copy in Argentina
The expiration of the Ozempic patent will lead to a significant decrease in prices as generic versions from Indian pharmaceutical companies enter the market, but Argentine copies remain notably expensive.
Ozempic in the SUS and without a patent: how weight loss pens have changed the world and what lies ahead
Rio de Janeiro becomes the first city in Brazil to offer the medication Ozempic through its public health system, marking a significant step in the fight against obesity.
VIDEOS: Good Morning on Friday, March 20, 2026
This segment covers various news items relevant to Brazil, including the decline in oil prices, an accident involving trucks and motorcycles after a bridge collapse, a car theft involving a baby, developments in a political case, patent issues related to Ozempic, and tax declaration updates.
Indian companies are queuing up to exploit Novo's patent expiry
Indian companies are preparing to launch cheaper weight loss medications following the expiration of Novo Nordisk's patent on semaglutide.
G1 Bahia and TV Bahia videos – Friday, March 20, 2026
The article covers various news segments including the execution of a wrestler in Iran linked to protests, issues with Ozempic patent in Brazil, delays in SUS dialysis funding, car theft in São Paulo, and the upcoming music festival Lollapalooza.
Daily Summary #1908: Vorcaro transferred to the Federal Police and opens the way for plea bargaining; IRS releases 2026 income tax program; Ozempic patent falls; Autumn will have above-average temperatures; Lollapalooza begins with eclectic first day
Vorcaro's transfer to the Federal Police marks a potential opening for plea bargaining, while other updates highlight developments in Brazil's income tax program, Ozempic patent situation, weather expectations for autumn, and the kick-off of Lollapalooza 2026.
Ozempic patent expires, but Brazil still lacks national alternatives; new pens may arrive by June
The patent for semaglutide, used in medications like Ozempic, expires soon, but Brazil has yet to see affordable national alternatives, with new versions anticipated by June after regulatory approvals.
Patent for Ozempic and Wegovy expires this Friday (20); understand what changes
The patent for semaglutide, the active ingredient in Ozempic and Wegovy, expires, allowing other companies to manufacture and sell similar medications in Brazil.
Ozempic at Banana Prices is a Threat to Buffets
The impending patent expiration of the weight-loss drug Ozempic is expected to lead to a significant increase in its availability and use, impacting various sectors like food and restaurants in Brazil.
Cheaper copies of Ozempic will soon flood the market. India's patent expires on Friday
India is set to see the expiration of a patent for the diabetes drug Ozempic, paving the way for cheaper alternatives to enter the market.
How the expiration of the Ozempic patent in India could change the global fight against obesity (and what the risks are)
The expiration of the semaglutide patent in India could lead to more affordable weight loss drugs, making them accessible to a larger population.
When Illia sought to regulate a conflictive market
The article discusses Argentina's former president Arturo Illia's attempts to regulate the contentious pharmaceutical patent market during his administration.
The End of the Pharmaceutical Lock: The Story Behind the Patent Resolution that Divided Laboratories for Decades
Argentina has lifted intellectual property restrictions on pharmaceuticals that had been in place since 2012, reflecting a long-standing conflict between domestic and foreign laboratories.
Ozempic and Wegovy: India's cheap weight-loss pens that could change the global battle against obesity
India is expected to reduce obesity rates significantly with the impending expiration of the semaglutide patent, allowing for cheaper generic versions of popular weight-loss drugs.
The H-hour for obesity drugs is Friday
The patent for the obesity treatment drug semaglutide will expire in India on Friday, leading to potential price reductions and increased market competition.
Ozempic and Wegovy: The Cheap Weight Loss Pens from India That Could Change the Global Fight Against Obesity
India is poised to significantly lower obesity rates with the upcoming expiration of the semaglutide patent, allowing local pharmaceutical companies to produce cheaper generic versions of Ozempic and Wegovy.
Patent Tax
A citizen expresses outrage over a newly introduced and retroactive patent tax imposed by the municipality of Guayaquil, which she claims she has never heard of and sees as an unjust financial burden.
The Ozempic patent falls in the largest countries, prices drop, and previously unknown data comes to light
The expiration of the Ozempic patent in populous countries like India and China paves the way for cheaper generic versions of GLP-1 medications, significantly impacting global health.
Daily Summary #1903: 56% of Brazilians say they have already decided their vote for president, according to Quaest; What to expect with the patent expiration of semaglutide and more
A recent survey reveals that 56% of Brazilians claim to have already made their decision on who to vote for in the presidential elections.
China leads world in anti-drone patents with US and South Korea far behind, law firm finds
China tops the globe in patent applications for anti-drone technology, significantly outpacing the US and South Korea amid rising security concerns.
Ozempic: With the expiration of the patent will prices fall? Will we have a generic version? See what to expect now
The patent on semaglutide, the active ingredient in Ozempic, expires in Brazil, possibly leading to lower prices and generic versions of the drug in the future.
Users are to blame for patent delays, says Inpi president at event
The president of Brazil's National Institute of Intellectual Property (Inpi) stated that delays in patent grants are primarily due to the negligence of users, including companies and universities.
Choose your favorite - the public sympathy of the award "Trademark of the Year 2025"!
The Patent Board of Latvia invites the public to vote for their favorite trademark as part of the "Trademark of the Year 2025" award to recognize the importance of trademarks in business.
Choose your favorite – the public's sympathy award "Trademark of the Year 2025”!
The public is invited to vote for the most appealing trademark in Latvia as part of the "Trademark of the Year 2025" award, aimed at recognizing the importance of trademarks in business and commerce.
‘I thought that by stopping the lease I no longer had to pay’: Guayaquil users with doubts about patent payments to municipal windows
Guayaquil residents are confused about their patent payment obligations after ceasing business operations, as they still receive notifications for payments even after closing their businesses.
Hypera bets on patent expiration of weight loss pen to boost sales
Hypera's president announced plans for significant sales growth following the expected patent expiration of semaglutide pharmaceuticals.
These are the people obligated to pay the municipal patent in Guayaquil
Authorities in Guayaquil have begun notifying individuals with an active tax registration about the Municipal Patent Tax applicable to economic activities.
Notifications for Municipal Patent Collection Generate Concern in Guayaquil: When Should It Be Paid and How Is the Amount Determined?
Residents of Guayaquil are concerned after receiving notifications about the Municipal Patent tax, sparking debate about its nature and the amounts owed.
Why Brazilian 'Ozempic' may take time and patent expiration probably won’t lower prices
The expiration of the semaglutide patent in Brazil will not lead to immediate price reductions for Ozempic due to regulatory and logistical challenges.
Why 'Brazilian Ozempic' may take time and the patent expiration won't lower prices
The expiration of the semaglutide patent in Brazil is unlikely to lead to immediate price reductions for Ozempic due to regulatory and manufacturing challenges.
The ‘Bold’ Gang Who Dealt in Samsung’s Confidential Corporate Messenger… "It's Valuable, So 7 Billion Won"
Former Samsung employees are accused of leaking confidential patent information and discussing payments for information on a corporate messenger, leading to multiple indictments.
TODAY IN HISTORY: The invention that changed the world was patented
Today marks the anniversary of Alexander Graham Bell patenting the telephone, a revolutionary invention that transformed global communication.
The Problem Solver Who Resolved Patent Disputes with Everyday Language... Lowering Language Barriers That Stopped Kant's Philosophy
This article profiles Jeong Woo-sung, a patent attorney and independent researcher who translated Kant's 'Critique of Pure Reason' into accessible language, making the complex work more approachable for the general public.
When the patent for aspirin was obtained... it was created by Hoffman working at Bayer company
On March 6, 1899, Bayer Company patented aspirin, a drug derived from a chemical found in willow tree bark.
Supreme Court Denies 'AI as Inventor', Dismissing Appeal from US Applicant
The Japanese Supreme Court upheld a lower court's decision rejecting a patent application that named an AI as the inventor, stating that inventors must be natural persons.
The Patent War over Healthcare Electrification Begins
The article discusses the onset of legal battles related to the electrification of healthcare in Czechia.
17 days before the patent expires, pharmaceutical company lowers the price of Rybelsus and offers free dose of Wegovy
Novo Nordisk has announced a significant price reduction for its medications Rybelsus and Wegovy, ahead of the expiration of the patent for Ozempic.
End of the semaglutide patent in 2026 intensifies market disputes among China, India, USA, Canada, and Brazil
The expiration of semaglutide's patent in 2026 is expected to ignite competition among major global markets including China, India, the USA, Canada, and Brazil, particularly in the lucrative obesity treatment sector.
The end of the best-selling prescription medication causes pain - 'Outrageous price'
The shortage of the widely-used anticoagulant apixaban in Finland has led to significant distress due to skyrocketing prices and limited access, caused by a patent dispute among pharmaceutical companies.
Unified Patent Court: first procedural experiences and the latest changes
The article discusses the establishment and current functioning of the Unified Patent Court (UPC) in Europe, highlighting both improvements and ongoing uncertainties.
Monitor Polski from February 25, 2026 (positions 238-244)
Announcement by the Minister of Sport and Tourism regarding the inclusion of a free market qualification for organizing and implementing ski tourism events in the Integrated Qualification System, along with various announcements from the Patent Office and Minister of Energy on different regulatory matters.
Brazilian pharmaceutical companies seek Indian technology for weight loss pen manufacturing
Brazilian pharmaceutical firms Biomm and Amoveri are pursuing Indian technology agreements to produce weight loss pens ahead of the patent expiration for Ozempic in 2026.
Pharmaceutical company Dr. Reddy's prepares to launch a cheap generic Ozempic in India in March
Indian pharmaceutical company Dr. Reddy’s Laboratories is set to launch a generic version of the diabetes drug Ozempic, named Obeda, in March 2026 following the expiration of the semaglutide patent.
IFMA wins first international patent in research on pineapple crown
IFMA, a Brazilian research institution, has obtained its first international patent for using pineapple crowns in industrial applications.
End of Ozempic patent could reduce price by up to 35%, says laboratory wanting to make generic
The expiration of the semaglutide patent in March is expected to lead to a price reduction of up to 35% for Ozempic, according to pharmaceutical company EMS, which is interested in producing a generic version.